A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets
A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets
Recruiting · NCT07124221 · Registry updated 2025-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets | brain disorder, central nervous system disorder, endocrine system disorder, hyperpituitarism, hyperprolactinemia, hypothalamic disorder, nervous system disorder, pituitary gland disorder | Recruiting | Phase 3 | 2025-10-02 | NCT07124221 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Changchun GeneScience Pharmaceutical Co., Ltd. | 50 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking Union Hospital, Chinese Academy of Medical Sciences | Beijing | China | 2 |